In Depth

Featured article

Anticipation rises for RSV rollout as positive data emerges

Also in this section

Continuous monitoring expands aseptic knowledge and data in real time

Molecular glues are the latest craze in pharma research, but what are they?

Using pharmacovigilance to turn reactive investigation into active discovery

Lenmeldy becomes world’s most expensive drug

Q&A: BARDA wants to back tech that can combat multiple infections, says director

05/14/2024 08:51:52
  • Home | Anticipation rises for RSV rollout as positive data emerges
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • phasetwo
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • Avenga Company Insight
  • In Depth
  • Anticipation rises for RSV rollout as positive data emerges
  • Continuous monitoring expands aseptic knowledge and data in real time
  • Molecular glues are the latest craze in pharma research, but what are they?
  • Using pharmacovigilance to turn reactive investigation into active discovery
  • Lenmeldy becomes world’s most expensive drug
  • Q&A: BARDA wants to back tech that can combat multiple infections, says director
  • Sponsored Supplements
  • ZETA
  • Nipro
  • Listings
  • Events
  • Innovation Rankings
  • Buyer's Guides
  • Next issue
04/18/2024 00:00:00